Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo.

Saved in:
Bibliographic Details
Title: Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo.
Authors: Foggetti G; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Li C; Department of Biology, Stanford University, Stanford, California., Cai H; Department of Genetics, Stanford University School of Medicine, Stanford, California., Hellyer JA; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California., Lin WY; Department of Genetics, Stanford University School of Medicine, Stanford, California., Ayeni D; Department of Pathology, Yale School of Medicine, New Haven, Connecticut., Hastings K; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Choi J; Department of Genetics, Yale School of Medicine, New Haven, Connecticut.; Department of Biomedical Sciences, Korea University College of Medicine, Seoul, Korea., Wurtz A; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Andrejka L; Department of Genetics, Stanford University School of Medicine, Stanford, California., Maghini DG; Department of Genetics, Stanford University School of Medicine, Stanford, California., Rashleigh N; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Levy S; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Homer R; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; VA Connecticut Healthcare System, Pathology and Laboratory Medicine Service, West Haven, Connecticut., Gettinger SN; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Diehn M; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, California.; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Wakelee HA; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Petrov DA; Department of Biology, Stanford University, Stanford, California., Winslow MM; Department of Genetics, Stanford University School of Medicine, Stanford, California. katerina.politi@yale.edu mwinslow@stanford.edu.; Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California.; Department of Pathology, Stanford University School of Medicine, Stanford, California., Politi K; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut. katerina.politi@yale.edu mwinslow@stanford.edu.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Source: Cancer discovery [Cancer Discov] 2021 Jul; Vol. 11 (7), pp. 1736-1753. Date of Electronic Publication: 2021 Mar 11.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2159-8290
DOI:10.1158/2159-8290.CD-20-1385